COMMUNIQUÉS West-GlobeNewswire

CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congress™ 2019
12/04/2019
NEWARK, Calif., April 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)
12/04/2019
TEL AVIV, Israel, April 12, 2019 (GLOBE NEWSWIRE) -- FameWave Ltd. a privately held biopharmaceutical company developing CM-24, which is being acquired by Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), today announced the [...]
Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference
12/04/2019
Adults with later-onset spinal muscular atrophy (SMA) who are not being treated show increased rates of hospital admissions, clinical interventions and mortality, indicating an unmet medical need Infants with pre- [...]
Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress™ 2019 (EASL)
12/04/2019
LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]
Better Choice Company Signs Memorandum of Understanding with Nutrisur S.A. for Development Rights of CBD Infused Pet Supplements
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) is pleased to announce that it has signed a memorandum of understanding (“MOU”) with Nutrisur S.A. (“ [...]
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
12/04/2019
Company to Host Investor Conference Call Today at 8:30 a.m. EDT / 5:30 a.m. PDT SAN DIEGO, April 12, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on [...]
Information on changes in the Management Boards of the subsidiaries of JSC Olainfarm and in authorization rights
12/04/2019
In addition to the previously published information on changes in the Management Board of JSC Olainfarm and of the recall of O. Grigorjevs, I. Krūkle, M. Raizbergs and V. Krušinskis from the position of a member of the [...]
Spring Bank Announces Positive Results from the Recently Completed Phase 2 Chronic Hepatitis B ACHIEVE Trial and Additional Inarigivir Studies
12/04/2019
Consistent reduction in HBV DNA demonstrated with higher inarigivir doses including in high viral burden HBeAg-positive patients 26% HBsAg responder population for all inarigivir doses showed mean HBsAg change of 0.8log [...]
Aleafia Health Applauds Commitment to Private Retail Expansion in Ontario Budget
12/04/2019
Company has Equity Stakes and Supply Agreements With Three Major Retail Partners Budget Announced Major Expansion of Cannabis Retail Licences in Canada’s Largest Province TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- [...]
AroCell´s 2018 Annual Report published
12/04/2019
AroCell today announces that the Annual Report for 2018 is now available on the company’s website: www.arocell.com . The Annual report is available on the following link: arocell.com/årsredovisning-2018 The report is [...]
GN Audio upgrades financial guidance for 2019
12/04/2019
GN Audio has had a very strong start to 2019, with the following preliminary numbers for Q1 2019: Revenue: DKK 1,333 million Organic revenue growth: 36% EBITA reported: DKK 192 million EBITA margin reported: 14.4% [...]
Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
12/04/2019
Strain-typing and AMR detection of clinical isolates based on ARESdb Set-up of own NGS service laboratory in Vienna, Austria Vienna, Austria, Holzgerlingen, Germany, and Amsterdam, The Netherlands, April 12, 2019, 08:00 [...]
DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
12/04/2019
Georges GAUDRIAULT, Scientific Director of DEINOVE, will give a talk at the ECCMID, at the ‘Therapeutics pipeline corner’, on this coming Sunday, April 14 th , in Amsterdam. He will describe the progress of the DNV3837 [...]
Basilea reports isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
12/04/2019
Basel, Switzerland, April 12, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that a broad range of posters and presentations on the antifungal isavuconazole (Cresemba ® ) and the antibiotic ceftobiprole ( [...]
PhaseBio Announces Pricing of Public Offering of Common Stock
12/04/2019
MALVERN, Pa., and SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Cooper Fitness Center Introduces Move.Laugh.Connect. Program
11/04/2019
Cooper Program For Total Well-being Extends Functional Years DALLAS, April 11, 2019 (GLOBE NEWSWIRE) -- Cooper Fitness Center announces a new program, Move.Laugh.Connect. (MLC) as a balanced program for total well-being [...]
Cerner and naviHealth Expand Relationship, Plan to Launch Offering for Bundled Payments for Care Improvement Advanced (BPCI Advanced)
11/04/2019
KANSAS CITY, Mo., April 11, 2019 (GLOBE NEWSWIRE) -- Health care providers that want to participate in Medicare’s Bundled Payments for Care Improvement Advanced program (BPCI Advanced) can soon look to Cerner , a global [...]
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
11/04/2019
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock [...]
KemPharm Completes KP415 Pre-NDA Meeting with FDA
11/04/2019
KP415 NDA Filing Anticipated in Late Q2 or Early Q3 2019 Conference Call Scheduled for Today, Thursday, April 11, 2019 at 5:00 p.m. ET CELEBRATION, Fla., April 11, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH [...]

Pages